Uy Ear
Stock Analyst at Mizuho
(3.7)
Main Sectors:
19 Stocks
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
QURE uniQure | Maintains: Outperform | 30 60 | 54.92 | 9.25% | 5 | Sep 25, 2025 | |
MBX MBX Biosciences | Maintains: Outperform | 38 56 | 16.69 | 235.53% | 2 | Sep 24, 2025 | |
ACAD ACADIA Pharmaceutica... | Maintains: Neutral | 23 24 | 21.8 | 10.09% | 14 | Aug 7, 2025 | |
SRPT Sarepta Therapeutics | Downgrades: Neutral | 40 14 | 22.64 | -38.16% | 8 | Jul 21, 2025 | |
TECX Tectonic Therapeutic | Maintains: Outperform | 51 85 | 15.24 | 457.74% | 2 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 20 21 | 19.92 | 5.42% | 14 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 23 1 | 2.32 | -56.9% | 1 | Dec 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 35 40 | 31.06 | 28.78% | 5 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 18 16 | n/a | n/a | 2 | Jul 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 40 | 10.19 | 292.54% | 1 | May 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 20 23 | 6.5 | 253.85% | 3 | Mar 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 116 140 | 137.03 | 2.17% | 10 | Feb 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 60 24 | n/a | n/a | 4 | Dec 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 35 16 | n/a | n/a | 1 | Nov 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 4 3 | n/a | n/a | 2 | Aug 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 36 40 | 188.64 | -78.8% | 1 | Jun 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 2 | n/a | n/a | 1 | Mar 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 10 | 2.44 | 309.84% | 1 | Mar 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 5 3 | 1.77 | 69.49% | 2 | Mar 1, 2023 |